Literature DB >> 23114601

Improved detection suggests all Merkel cell carcinomas harbor Merkel polyomavirus.

Scott J Rodig1, Jingwei Cheng, Jacek Wardzala, Andrew DoRosario, Jessica J Scanlon, Alvaro C Laga, Alejandro Martinez-Fernandez, Justine A Barletta, Andrew M Bellizzi, Subhashini Sadasivam, Dustin T Holloway, Dylan J Cooper, Thomas S Kupper, Linda C Wang, James A DeCaprio.   

Abstract

A human polyomavirus was recently discovered in Merkel cell carcinoma (MCC) specimens. The Merkel cell polyomavirus (MCPyV) genome undergoes clonal integration into the host cell chromosomes of MCC tumors and expresses small T antigen and truncated large T antigen. Previous studies have consistently reported that MCPyV can be detected in approximately 80% of all MCC tumors. We sought to increase the sensitivity of detection of MCPyV in MCC by developing antibodies capable of detecting large T antigen by immunohistochemistry. In addition, we expanded the repertoire of quantitative PCR primers specific for MCPyV to improve the detection of viral DNA in MCC. Here we report that a novel monoclonal antibody detected MCPyV large T antigen expression in 56 of 58 (97%) unique MCC tumors. PCR analysis specifically detected viral DNA in all 60 unique MCC tumors tested. We also detected inactivating point substitution mutations of TP53 in the two MCC specimens that lacked large T antigen expression and in only 1 of 56 tumors positive for large T antigen. These results indicate that MCPyV is present in MCC tumors more frequently than previously reported and that mutations in TP53 tend to occur in MCC tumors that fail to express MCPyV large T antigen.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23114601      PMCID: PMC3533549          DOI: 10.1172/JCI64116

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  48 in total

Review 1.  Merkel cell carcinoma.

Authors:  Wolfram Goessling; Phillip H McKee; Robert J Mayer
Journal:  J Clin Oncol       Date:  2002-01-15       Impact factor: 44.544

2.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

3.  Hybrid capture and next-generation sequencing identify viral integration sites from formalin-fixed, paraffin-embedded tissue.

Authors:  Eric J Duncavage; Vincent Magrini; Nils Becker; Jon R Armstrong; Ryan T Demeter; Todd Wylie; Haley J Abel; John D Pfeifer
Journal:  J Mol Diagn       Date:  2011-05       Impact factor: 5.568

4.  Cytoskeletal differences between human neuroendocrine tumors: a cytoskeletal protein of molecular weight 46,000 distinguishes cutaneous from pulmonary neuroendocrine neoplasms.

Authors:  R Moll; W W Franke
Journal:  Differentiation       Date:  1985       Impact factor: 3.880

5.  Merkel cell carcinoma and HIV infection.

Authors:  Eric A Engels; Morten Frisch; James J Goedert; Robert J Biggar; Robert W Miller
Journal:  Lancet       Date:  2002-02-09       Impact factor: 79.321

6.  p53 targets simian virus 40 large T antigen for acetylation by CBP.

Authors:  Danielle L Poulin; Andrew L Kung; James A DeCaprio
Journal:  J Virol       Date:  2004-08       Impact factor: 5.103

7.  Cytokeratin 20 in human carcinomas. A new histodiagnostic marker detected by monoclonal antibodies.

Authors:  R Moll; A Löwe; J Laufer; W W Franke
Journal:  Am J Pathol       Date:  1992-02       Impact factor: 4.307

8.  Clonal p53 mutation in primary cervical cancer: association with human-papillomavirus-negative tumours.

Authors:  T Crook; D Wrede; J A Tidy; W P Mason; D J Evans; K H Vousden
Journal:  Lancet       Date:  1992-05-02       Impact factor: 79.321

9.  Mutation analysis of P73 and TP53 in Merkel cell carcinoma.

Authors:  M Van Gele; M Kaghad; J H Leonard; N Van Roy; J M Naeyaert; M L Geerts; S Van Belle; V Cocquyt; J Bridge; R Sciot; C De Wolf-Peeters; A De Paepe; D Caput; F Speleman
Journal:  Br J Cancer       Date:  2000-02       Impact factor: 7.640

10.  Molecular variants of the ATM gene in Hodgkin's disease in children.

Authors:  E Liberzon; S Avigad; I Yaniv; B Stark; G Avrahami; Y Goshen; R Zaizov
Journal:  Br J Cancer       Date:  2004-01-26       Impact factor: 7.640

View more
  73 in total

1.  Cytokeratin 20-negative Merkel cell carcinoma is infrequently associated with the Merkel cell polyomavirus.

Authors:  Andrew G Miner; Rajiv M Patel; Deborah A Wilson; Gary W Procop; Eugen C Minca; Douglas R Fullen; Paul W Harms; Steven D Billings
Journal:  Mod Pathol       Date:  2014-11-14       Impact factor: 7.842

2.  Reply to Commentary on "Cytokeratin 20-negative Merkel cell carcinoma is infrequently associated with the Merkel cell polyomavirus".

Authors:  Andrew G Miner; Rajiv M Patel; Deborah Wilson; Gary W Procop; Eugen Minca; Douglas R Fullen; Paul W Harms; Steven D Billings
Journal:  Mod Pathol       Date:  2016-01       Impact factor: 7.842

Review 3.  Reprogramming of cellular metabolic pathways by human oncogenic viruses.

Authors:  John G Purdy; Micah A Luftig
Journal:  Curr Opin Virol       Date:  2019-11-22       Impact factor: 7.090

4.  Molecular Profiling of Multiple Primary Merkel Cell Carcinoma to Distinguish Genetically Distinct Tumors From Clonally Related Metastases.

Authors:  Kelly L Harms; Lorena Lazo de la Vega; Daniel H Hovelson; Samantha Rahrig; Andi K Cani; Chia-Jen Liu; Douglas R Fullen; Min Wang; Aleodor A Andea; Christopher K Bichakjian; Timothy M Johnson; Scott A Tomlins; Paul W Harms
Journal:  JAMA Dermatol       Date:  2017-06-01       Impact factor: 10.282

Review 5.  Merkel Cell Carcinoma in the Age of Immunotherapy: Facts and Hopes.

Authors:  Aric Colunga; Thomas Pulliam; Paul Nghiem
Journal:  Clin Cancer Res       Date:  2017-12-07       Impact factor: 12.531

6.  Merkel cell polyomavirus T antigens promote cell proliferation and inflammatory cytokine gene expression.

Authors:  Kathleen F Richards; Anna Guastafierro; Masahiro Shuda; Tuna Toptan; Patrick S Moore; Yuan Chang
Journal:  J Gen Virol       Date:  2015-12       Impact factor: 3.891

7.  T-cell responses to oncogenic merkel cell polyomavirus proteins distinguish patients with merkel cell carcinoma from healthy donors.

Authors:  Rikke Lyngaa; Natasja Wulff Pedersen; David Schrama; Charlotte Albæk Thrue; Dafina Ibrani; Ozcan Met; Per Thor Straten; Paul Nghiem; Jürgen C Becker; Sine Reker Hadrup
Journal:  Clin Cancer Res       Date:  2014-02-13       Impact factor: 12.531

8.  Regression of metastatic Merkel cell carcinoma following transfer of polyomavirus-specific T cells and therapies capable of re-inducing HLA class-I.

Authors:  Aude G Chapuis; Olga K Afanasiev; Jayasri G Iyer; Kelly G Paulson; Upendra Parvathaneni; Joo Ha Hwang; Ivy Lai; Ilana M Roberts; Heather L Sloan; Shailender Bhatia; Kendall C Shibuya; Ted Gooley; Cindy Desmarais; David M Koelle; Cassian Yee; Paul Nghiem
Journal:  Cancer Immunol Res       Date:  2014-01       Impact factor: 11.151

9.  miRNA-34a underexpressed in Merkel cell polyomavirus-negative Merkel cell carcinoma.

Authors:  Tuukka Veija; Helka Sahi; Virve Koljonen; Tom Bohling; Sakari Knuutila; Neda Mosakhani
Journal:  Virchows Arch       Date:  2014-12-10       Impact factor: 4.064

Review 10.  Merkel cell polyomavirus infection and Merkel cell carcinoma.

Authors:  Wei Liu; Margo MacDonald; Jianxin You
Journal:  Curr Opin Virol       Date:  2016-08-10       Impact factor: 7.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.